Life Sciences Real Estate #93

Conren Tramway's €65 million Esplugues, Campus sale in Barcelona, plus three other sales deals.
In:

Good morning,

We have thirteen deals this week. Let's jump into them.

In today's free edition:
🇪🇸 Conren Tramway selling Esplugues Campus in Barcelona for up to €65 million
🇬🇧 £51 million National Cryogenic Facility to be built at Sci-Tech Daresbury

🔒 For paying members only:
🇳🇱 Novaxia sells life sciences complex in Rotterdam metropolitan region
🇩🇪 TSC Real Estate acquires Gesundheitsforum Regensburg
🇩🇪 Walter Beteiligungen to develop 5,000 sq m medical centre in Augsburg
🇩🇪 Preventive Care Center expands to 2,000 sq m at The One in Nuremberg
🇩🇪 Hagedorn and Impulse Therapiezentren sign 10-year lease in Bielefeld
🇩🇪 Purealis acquires Upper Bavaria lab property in Velaris sale-and-leaseback
🇬🇧 Brunel Healthcare takes 142,386 sq ft at Tetron142 in Swadlincote
🇬🇧 Dandy opens UK laboratory at St John's Innovation Park, Cambridge
🇮🇪 Kerry opens expanded biotechnology manufacturing facility in Cork
🇫🇷 Construction begins on HealthTech Station deeptech incubator in Tours
🇪🇸 SID to invest €16 million in new laboratory buildings at Barcelona campus

Subscribe here to unlock.

Enjoy today's newsletter,
— Stephen Ryan


Conren Tramway selling Esplugues Campus in Barcelona for up to €65 million

Part of Esplugues Campus (source: conrentramway.com)

Conren Tramway is selling its Esplugues Campus, an 18,000 sq m office-led life sciences scheme in Esplugues de Llobregat, a life sciences cluster on the outskirts of Barcelona.

The asset, which has been repositioned from a former Braun industrial site into an office and laboratory campus targeting pharmaceutical and technology occupiers, is expected to trade for €60 million to €65 million.

CBRE and JLL have been mandated on the sale, and the process is understood to be at an early stage.

The campus is close to major pharmaceutical companies, hospitals and research centres and has good transport links to the city centre.

💡
Need deeper insight into life sciences real estate?
In addition to this newsletter, we deliver bespoke research and strategic analysis for investors and developers, from acquisition support to market mapping and custom reporting. Hit reply to discuss your next project.

£51 million National Cryogenic Facility to be built at Sci-Tech Daresbury

Sci-Tech Daresbury campus (source: liverpoolcityregion-ca.co.uk)

A £51 million National Cryogenic Facility, funded through UK Research and Innovation's (UKRI) Infrastructure Fund and announced in March 2026, is to be built at the Science and Technology Facilities Council’s Daresbury Laboratory on the Sci-Tech Daresbury campus in Cheshire.

The open-access facility will provide ultra-low temperature environments operating close to absolute zero and is expected to increase UK cryogenic testing capacity by approximately six times.

It will support quantum computing hardware, superconducting magnets for fusion energy, next-generation MRI systems and hydrogen-powered aviation, with potential downstream benefits for advanced medical imaging and quantum-enabled drug discovery.

The facility reinforces Sci-Tech Daresbury’s role as a cross-disciplinary cluster where quantum technologies, healthcare technologies and wider research infrastructure intersect.

Written by
Stephen Ryan
Stephen is an independent real estate researcher and CFA charterholder who founded Life Sciences Real Estate in 2022.

Stay on top of the life sciences real estate markets in Europe

Join us
Great! You’ve successfully signed up.
Welcome back! You've successfully signed in.
You've successfully subscribed to Life Sciences Real Estate.
Your link has expired.
Success! Check your email for magic link to sign-in.
Success! Your billing info has been updated.
Your billing was not updated.